Apomorphine (pharmacokinetics) < Apomorphine (pharmacology) < Apomorphine (therapeutic use)

Facettes :

List of bibliographic references indexed by Apomorphine (pharmacology)

Number of relevant bibliographic references: 16.

Ident.	Authors (with country if any)	Title
000767 (2013)	Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta	Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
001806 (2011)	Estelle Dellapina [France] ; Angélique Gerdelat-Mas [France] ; Fabienne Ory-Magne [France] ; Laure Pourcel [France] ; Monique Galitzky [France] ; Fabienne Calvas [France] ; Marion Simonetta-Moreau [France] ; Claire Thalamas [France] ; Pierre Payoux [France] ; Christine Brefel-Courbon [France]	Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study
002D65 (2007)	Martin Köllensperger [Autriche] ; Nadia Stefanova [Autriche] ; Markus Reindl [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]	Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy
003742 (2005)	Katherine L. Widnell [États-Unis] ; Cynthia Comella [États-Unis]	Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations
004481 (2002)	Guillermo Paradiso [Canada] ; Farooq Khan [Canada] ; Robert Chen [Canada]	Effects of apomorphine on flexor reflex and periodic limb movement
004520 (2002)		DA agonists ‐ Non‐Ergot derivaties: Apomorphine
004836 (2001)	Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]	Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
004A78 (2000)	Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	Endogenous dopaminergic tone and dopamine agonist action
004C58 (1999)	Anette Schrag [Royaume-Uni] ; Ludwig Schelosky [Allemagne] ; Udo Scholz [Allemagne] ; Werner Poewe [Autriche]	Reduction of parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single‐dose challenges
004D38 (1999)	Marcelo Merello [Argentine] ; Andrew Lees (neurologue) [Royaume-Uni] ; Jorge Balej [Argentine] ; Angel Cammarota [Argentine] ; Ram N Leiguarda [Argentine]	GPi Firing rate modification during beginning‐of‐dose motor deterioration following acute administration of apomorphine
004E08 (1999)	Edna Grünblatt [Israël] ; Silvia Mandel [Israël] ; Tamara Berkuzki [Israël] ; M. B. H. Youdim [Israël]	Apomorphine protects against MPTP‐induced neurotoxicity in mice
005070 (1998)	Michael Gassen [Allemagne] ; Aviva Gross [Israël] ; Moussa B. H. Youdim [Israël]	Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6‐Hydroxydopamine
005582 (1996)	G. K. Wenning [Royaume-Uni] ; R. Granata [Italie] ; P. M. Laboyrie ; N. P. Quinn [Royaume-Uni] ; Jenner ; C. D. Marsden [Royaume-Uni]	Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration
005864 (1995)	Giovanni Fabbrini [Italie] ; Fabio Baronti [Italie] ; Stefano Ruggieri [Italie] ; Gian Luigi Lenzi [Italie]	Meningioma‐induced loss of antiparkinsonian response to levodopa
005942 (1995)	Gancher [États-Unis] ; John G. Nutt [États-Unis] ; William R. Woodward [États-Unis]	Apomorphine infusional therapy in parkinson's disease: Clinical utility and lack of tolerance
005D36 (1993)	Broussolle [France] ; L. Cinotti [France] ; Pierre Pollak [France] ; P. Landais [France] ; D. Le Bars [France] ; G. Galy [France] ; F. Lavenne [France] ; Y. Khalfallah [France] ; G. Chazot [France] ; F. Mauguière [France]	Relief of akinesia by apomorphine and cerebral metabolic changes in parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Apomorphine (pharmacology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Apomorphine (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Apomorphine (pharmacology)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024